| 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| Gross margin | -65,7 € | -3.0% | -63,8 € | -0.3% | -63,6 € | +95.5% | -1,4 k € | |
| EBITDA | -650,4 € | +7.0% | -699,1 € | -25.5% | -557,0 € | +75.0% | -2,2 k € | |
| Operating profit | -650,4 € | +7.0% | -699,1 € | -25.5% | -557,0 € | +75.0% | -2,2 k € | |
| Profit/loss | -830,4 € | +2.2% | -849,1 € | -20.1% | -707,0 € | +72.5% | -2,6 k € | |
| Equity | -2,0 k € | -73.9% | -1,1 k € | -308.6% | -275,2 € | -163.7% | 431,9 € | |
| Total assets | 1,2 k € | +231.5% | 375,7 € | -69.3% | 1,2 k € | +57.2% | 779,4 € | |
| Cash | 974,9 € | +825.5% | 105,3 € | -89.0% | 954,5 € | +87.5% | 509,0 € | |
| Debts | 3,2 k € | +113.3% | 1,5 k € | 0.0% | 1,5 k € | +331.7% | 347,5 € | |
Source: Belgian Official Gazette
Private limited company · Puurs-Sint-Amands · incorporated on 29/01/2021
Private limited company loss-making in the latest fiscal year. Cash position rising (+825.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Inno Pharma is a Private limited company incorporated in 2021. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Puurs-Sint-Amands.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.